Jan 27, 2017 8:30am EST Court Schedules Hearing To Consider Approval Of Settlement Of Derivative Action
Sep 29, 2016 8:30am EDT iBio Proprietary Technology Advances Neonatal Respiratory Distress Syndrome Drug Development for South African Biotech Company AzarGen Biotechnologies (Pty) Ltd
Jul 05, 2016 8:31am EDT iBio, Inc. Receives FDA Orphan Drug Designation for Fibrosis Product Candidate
Jun 29, 2016 8:31am EDT iBio, Inc. Receives New Patent for Its Biotherapeutic Products for Treatment of Fibrosis
Jun 07, 2016 8:31am EDT Texas A&M University System and iBio Execute Joint Development Agreement for Plant-Produced Pharmaceuticals
